Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
EDULEARN ... Proceedings|March 9, 2022
BUILDING INFRASTRUCTURE LEADING TO DIVERSITY PROGRAM AT XAVIER UNIVERSITY OF LOUISIANA, <i>PROJECT PATHWAYS</i>M Foroozesh, M Giguette, K Morgan, et al.SAR and QSAR in Environmental Research|October 19, 2011
QSAR models of cytochrome P450 enzyme 1A2 inhibitors using CoMFA, CoMSIA and HQSARJ Sridhar, M Foroozesh, C L Klein StevensChemical Research in Toxicology|January 1, 1992
Release of iron from ferritin by aqueous extracts of cigarette smokeJ J Moreno, M Foroozesh, D F Church, et al.International Journal of Pharmaceutics|May 22, 2007
Preparation and in vitro evaluation of carrier erythrocytes for RES-targeted delivery of interferon-alpha 2bM Hamidi, A H Zarrin, M Foroozesh, et al.EDULEARN ... Proceedings|March 16, 2022
CLOSING THE LEAK: KEEPING LATE-DECIDING STUDENTS IN THE PIPELINE TO BIOMEDICAL RESEARCH CAREERSM Foroozesh, K Morgan, T S Coston, et al.Toxicology and Applied Pharmacology|December 3, 1999
Metabolism-based polycyclic aromatic acetylene inhibition of CYP1B1 in 10T1/2 cells potentiates aryl hydrocarbon receptor activityD L Alexander, L Zhang, M Foroozesh, et al.Chemical Research in Toxicology|January 1, 1997
Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymesM Foroozesh, G Primrose, Z Guo, et al.Chemical Research in Toxicology|October 7, 1998
Selectivity of polycyclic inhibitors for human cytochrome P450s 1A1, 1A2, and 1B1T Shimada, H Yamazaki, M Foroozesh, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 14, 1997
Inactivation of cytochrome P450s 2B1, 2B4, 2B6, and 2B11 by arylalkynesE S Roberts, N E Hopkins, M Foroozesh, et al.Journal of Natural Products|October 24, 1998
Antimycobacterial activities of dehydrocostus lactone and its oxidation productsC L Cantrell, I S Nuñez, J Castañeda-Acosta, et al.Pageof 2